NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.

被引：0
|
作者：
Ma, Daniel
Galanis, Evanthia
Schiff, David
Wu, Wenting
Peller, Patrick J.
Giannini, Caterina
Brown, Paul D.
Uhm, Joon H.
McGraw, Steven
Jaeckle, Kurt A.
Flynn, Patrick J.
Buckner, Jan C.
Sarkaria, Jann Nagina
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Virginia, Med Ctr, Charlottesville, VA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Sioux Community Canc Consortium, Sioux Falls, SD USA
[5] Mayo Clin, Jacksonville, FL 32224 USA
[6] Metro Minnesota Community Clin Oncol Project, St Louis Pk, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2031
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
    Ma, Daniel J.
    Galanis, Evanthia
    Anderson, S. Keith
    Schiff, David
    Kaufmann, Timothy J.
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Flynn, Patrick J.
    Ligon, Keith L.
    Buckner, Jan C.
    Sarkaria, Jann N.
    NEURO-ONCOLOGY, 2015, 17 (09) : 1261 - 1269
  • [2] NORTH CENTRAL CANCER TREATMENT GROUP PHASE I TRIAL N057K OF EVEROLIMUS (RAD001) AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Sarkaria, Jann N.
    Galanis, Evanthia
    Wu, Wenting
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Buckner, Jan C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 468 - 475
  • [3] GENETIC PROFILING FOR EARLY EVEROLIMUS SENSITIVITY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS ENROLLED ON NCCTG N057K
    Ma, Daniel
    Galanis, Eva
    Peller, Patrick
    Ligon, Keith
    Giannini, Caterina
    Sarkaria, Jann
    NEURO-ONCOLOGY, 2014, 16
  • [4] FLT-PET analysis of early response to everolimus in newly diagnosed glioblastoma patients enrolled on NCCTG N057K
    Sarkaria, J. N.
    Peller, P. J.
    Galanis, E.
    Jacobson, M. S.
    Wu, W.
    Jaeckle, K. A.
    Buckner, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
    Brown, Paul D.
    Krishnan, Sunil
    Sarkaria, Jann N.
    Wu, Wenting
    Jaeckle, Kurt A.
    Uhm, Joon H.
    Geoffroy, Francois J.
    Arusell, Robert
    Kitange, Gaspar
    Jenkins, Robert B.
    Kugler, John W.
    Morton, Roscoe F.
    Rowland, Kendrith M., Jr.
    Mischel, Paul
    Yong, William H.
    Scheithauer, Bernd W.
    Schiff, David
    Giannini, Caterina
    Buckner, Jan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5603 - 5609
  • [6] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
    Molaie, Donna
    Lai, Albert
    Ellingson, Benjamin M.
    Thien Nguyen
    Bahng, Hye Hyun
    Filka, Emese
    Green, Stacey
    Pope, Whitney B.
    Leng, Mei
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Liz
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [9] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Ciesielski, Michael J.
    Reardon, David A.
    Abad, Ajay
    Curry, William
    Wong, Eric
    Peereboom, David
    Figel, Sheila
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry
    Liu, Song
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Khosla, Atulya
    Casucci, Danielle
    Mechtler, Laszlo
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [10] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
12345